Our Team

Meet the individuals transforming the therapeutic landscape

Senior Management & Leadership Team

Our leadership team has deep scientific and clinical expertise in fibrosis and oncology, a clear commercial vision, and a track record in raising finance and bringing therapies into the clinic.

By harnessing the insights generated through our proprietary human extracellular matrix (ECM) platform, we aim to realise our vision to develop life-changing therapeutics and create a healthier future for patients with life-threatening inflammation, fibrotic diseases and cancers.

Giuseppe Mazza, PhD

Chief Executive Officer and Co-Founder

Chris Stevenson, PhD

Chief Scientific Officer

Matt Edwards, PhD

SVP, Discovery

Emma Huang, PhD

VP of Platform and Technology

Amélie Fortin

Head of People & Culture

Andy Roland-Price

Head of Finance

Board of Directors

Eduardo Bravo

Chairman of the Board

Dr Giuseppe Mazza

Chief Executive Officer and Co-Founder

Mike Platt

Investor Director

Gianluca Rossetti

Investor Director

David Dally

Independent Director

Stephen Brindle

Investor Director

Sonia Quaratino, MD, PhD

Independent Director

Scientific Advisors

Our Scientific Advisors include renowned global academic and clinical leaders in diseases of the gastrointestinal tract, liver, pancreas, skin and lung fibrosis and cancers.

Professor Massimo Pinzani, MD, PhD, FAASLD, FRCP

Alex Lugovskoy, PhD

Doug Thorburn, MD

Scott Turner, PhD

Emmanuel Tsochatzis, MD, MSC, FEBTM, FRCP, PHD

Tu Vinh Luong, MD, FRCPATH

Antonio Di Sabatino, MD

Hendrik-Tobias Arkenau, MD, PhD, FRCP

Giuseppe Fusai, MD